
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $418.6M | $473.3M | $563.2M | $557.1M | $494.8M | |
Revenue Growth (YoY) | -4.47% | 13.07% | 18.99% | -1.08% | -11.18% | |
Cost of Revenues | $268.8M | $311.5M | $394.2M | $374.1M | $298.2M | |
Gross Profit | $149.8M | $161.8M | $169M | $183M | $196.6M | |
Gross Profit Margin | 35.79% | 34.19% | 30.01% | 32.85% | 39.73% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -$5.2M | -$4.6M | -$2.4M | -- | -$200K | |
Operating Expenses | $78.4M | $84M | $88.5M | $95.9M | $106M | |
Operating Income | $71.4M | $77.8M | $80.5M | $87.1M | $90.6M | |
Net Interest Expenses | $23.8M | $25.6M | $25.5M | $28.7M | $29.3M | |
EBT. Incl. Unusual Items | $42.4M | $47.6M | $52.6M | $58.4M | $61.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $10.2M | $11.5M | $11.2M | $13.2M | $14M | |
Net Income to Company | $32.2M | $36.1M | $41.4M | $45.2M | $47.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $32.2M | $36.1M | $41.4M | $45.2M | $47.1M | |
Basic EPS (Cont. Ops) | $2.15 | $2.35 | $2.59 | $2.82 | $2.93 | |
Diluted EPS (Cont. Ops) | $2.15 | $2.35 | $2.59 | $2.82 | $2.92 | |
Weighted Average Basic Share | $15M | $15.4M | $16M | $16M | $16.1M | |
Weighted Average Diluted Share | $15M | $15.4M | $16M | $16.1M | $16.1M | |
EBITDA | $123.3M | $134.3M | $143.5M | $160.7M | $174.9M | |
EBIT | $68.8M | $74.8M | $80.9M | $93.3M | $98.8M | |
Revenue (Reported) | $418.6M | $473.3M | $563.2M | $557.1M | $494.8M | |
Operating Income (Reported) | $71.4M | $77.8M | $80.5M | $87.1M | $90.6M | |
Operating Income (Adjusted) | $68.8M | $74.8M | $80.9M | $93.3M | $98.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $138.8M | $192.6M | $220.2M | $178.7M | $170.8M | |
Revenue Growth (YoY) | 6.44% | 38.76% | 14.33% | -18.85% | -4.42% | |
Cost of Revenues | $84.3M | $134.5M | $156.7M | $108.8M | $95M | |
Gross Profit | $54.5M | $58.1M | $63.5M | $69.9M | $75.8M | |
Gross Profit Margin | 39.27% | 30.17% | 28.84% | 39.12% | 44.38% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -$1.3M | -$700K | -- | -$300K | -$100K | |
Operating Expenses | $21.1M | $22.3M | $24M | $25.7M | $29.6M | |
Operating Income | $33.4M | $35.8M | $39.5M | $44.2M | $46.2M | |
Net Interest Expenses | $6.7M | $6.2M | $7.1M | $7.3M | $9.1M | |
EBT. Incl. Unusual Items | $25.4M | $28.9M | $32.4M | $36.6M | $37M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6.5M | $7.4M | $8.3M | $9.4M | $9.5M | |
Net Income to Company | $18.9M | $21.5M | $24.1M | $27.2M | $27.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $18.9M | $21.5M | $24.1M | $27.2M | $27.5M | |
Basic EPS (Cont. Ops) | $1.26 | $1.35 | $1.51 | $1.69 | $1.69 | |
Diluted EPS (Cont. Ops) | $1.26 | $1.35 | $1.51 | $1.69 | $1.69 | |
Weighted Average Basic Share | $15M | $16M | $16M | $16.1M | $16.2M | |
Weighted Average Diluted Share | $15M | $16M | $16M | $16.1M | $16.2M | |
EBITDA | $47.2M | $51M | $57.3M | $63.9M | $69.4M | |
EBIT | $32.3M | $35.5M | $40.6M | $45.9M | $47.7M | |
Revenue (Reported) | $138.8M | $192.6M | $220.2M | $178.7M | $170.8M | |
Operating Income (Reported) | $33.4M | $35.8M | $39.5M | $44.2M | $46.2M | |
Operating Income (Adjusted) | $32.3M | $35.5M | $40.6M | $45.9M | $47.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $427M | $527.1M | $590.8M | $515.6M | $486.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $270.3M | $361.7M | $416.4M | $326.2M | $284.4M | |
Gross Profit | $156.7M | $165.4M | $174.4M | $189.4M | $202.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -$5M | -$4M | -$1.7M | -$200K | -- | |
Operating Expenses | $79.5M | $85.2M | $90.2M | $97.6M | $109.9M | |
Operating Income | $77.2M | $80.2M | $84.2M | $91.8M | $92.6M | |
Net Interest Expenses | $24.3M | $25.1M | $26.4M | $28.9M | $31.1M | |
EBT. Incl. Unusual Items | $47.9M | $51.1M | $56.1M | $62.6M | $61.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12M | $12.4M | $12.1M | $14.3M | $14.1M | |
Net Income to Company | $35.9M | $38.7M | $44M | $48.3M | $47.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $35.9M | $38.7M | $44M | $48.3M | $47.4M | |
Basic EPS (Cont. Ops) | $2.39 | $2.46 | $2.75 | $3.00 | $2.93 | |
Diluted EPS (Cont. Ops) | $2.39 | $2.46 | $2.75 | $3.00 | $2.92 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $130.2M | $137.9M | $149.8M | $167.3M | $180.4M | |
EBIT | $74.3M | $77.8M | $86M | $98.6M | $100.6M | |
Revenue (Reported) | $427M | $527.1M | $590.8M | $515.6M | $486.9M | |
Operating Income (Reported) | $77.2M | $80.2M | $84.2M | $91.8M | $92.6M | |
Operating Income (Adjusted) | $74.3M | $77.8M | $86M | $98.6M | $100.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $138.8M | $192.6M | $220.2M | $178.7M | $170.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $84.3M | $134.5M | $156.7M | $108.8M | $95M | |
Gross Profit | $54.5M | $58.1M | $63.5M | $69.9M | $75.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -$1.3M | -$700K | -- | -$300K | -$100K | |
Operating Expenses | $21.1M | $22.3M | $24M | $25.7M | $29.6M | |
Operating Income | $33.4M | $35.8M | $39.5M | $44.2M | $46.2M | |
Net Interest Expenses | $6.7M | $6.2M | $7.1M | $7.3M | $9.1M | |
EBT. Incl. Unusual Items | $25.4M | $28.9M | $32.4M | $36.6M | $37M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6.5M | $7.4M | $8.3M | $9.4M | $9.5M | |
Net Income to Company | $18.9M | $21.5M | $24.1M | $27.2M | $27.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $18.9M | $21.5M | $24.1M | $27.2M | $27.5M | |
Basic EPS (Cont. Ops) | $1.26 | $1.35 | $1.51 | $1.69 | $1.69 | |
Diluted EPS (Cont. Ops) | $1.26 | $1.35 | $1.51 | $1.69 | $1.69 | |
Weighted Average Basic Share | $15M | $16M | $16M | $16.1M | $16.2M | |
Weighted Average Diluted Share | $15M | $16M | $16M | $16.1M | $16.2M | |
EBITDA | $47.2M | $51M | $57.3M | $63.9M | $69.4M | |
EBIT | $32.3M | $35.5M | $40.6M | $45.9M | $47.7M | |
Revenue (Reported) | $138.8M | $192.6M | $220.2M | $178.7M | $170.8M | |
Operating Income (Reported) | $33.4M | $35.8M | $39.5M | $44.2M | $46.2M | |
Operating Income (Adjusted) | $32.3M | $35.5M | $40.6M | $45.9M | $47.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6M | $6.5M | $9M | $6.5M | $6.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $62M | $66.9M | $73.8M | $75M | $75M | |
Inventory | $9.1M | $9.6M | $13.2M | $14.5M | $15.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $6.4M | $8.1M | $8M | $8.3M | $8.4M | |
Total Current Assets | $139.3M | $159.7M | $194.8M | $177.1M | $188.8M | |
Property Plant And Equipment | $1.2B | $1.3B | $1.3B | $1.4B | $1.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $12.8M | $9.8M | $11.8M | $13.7M | $17.5M | |
Total Assets | $1.5B | $1.5B | $1.6B | $1.7B | $1.8B | |
Accounts Payable | $33.2M | $52.4M | $68.6M | $47.7M | $49.7M | |
Accrued Expenses | -- | -- | -- | $6M | $8.4M | |
Current Portion Of Long-Term Debt | $8.5M | $8.2M | $6.7M | $4.9M | $4.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | $1.5M | $1.9M | $1.8M | |
Other Current Liabilities | $39.4M | $48.3M | $66.3M | $52.3M | $57.4M | |
Total Current Liabilities | $136.1M | $173.5M | $260.1M | $277.3M | $228.7M | |
Long-Term Debt | $523.1M | $497.8M | $489.1M | $509.1M | $638.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B | |
Common Stock | $285.5M | $332.3M | $335.1M | $337.8M | $341.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $389M | $448.3M | $467.4M | $489.1M | $512.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $389.2M | $448.5M | $467.6M | $489.3M | $512.5M | |
Total Liabilities and Equity | $1.5B | $1.5B | $1.6B | $1.7B | $1.8B | |
Cash and Short Terms | $6M | $6.5M | $9M | $6.5M | $6.3M | |
Total Debt | $586.3M | $570.1M | $611.8M | $676M | $749.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6.1M | $6.5M | $6.8M | $6.3M | $10.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $73.2M | $81.9M | $92.2M | $83.9M | $95.5M | |
Inventory | $9.6M | $9.9M | $13.2M | $14.3M | $16.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $7.9M | $7.8M | $9.4M | $75.6M | $64.9M | |
Total Current Assets | $132.7M | $163.1M | $197.9M | $189.4M | $195.5M | |
Property Plant And Equipment | $1.2B | $1.3B | $1.3B | $1.4B | $1.6B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $17.9M | $16.4M | $18.2M | $21M | $22.9M | |
Total Assets | $1.5B | $1.6B | $1.6B | $1.7B | $1.9B | |
Accounts Payable | $28.7M | $39M | $46.3M | $37.9M | $42.9M | |
Accrued Expenses | $6.8M | $6.4M | $6.1M | $7.2M | $7.9M | |
Current Portion Of Long-Term Debt | $8.5M | $8.2M | $6.7M | $4.9M | $4.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $1.8M | |
Other Current Liabilities | $41.3M | $39.6M | $53.6M | $47.1M | $53.5M | |
Total Current Liabilities | $122.9M | $157.7M | $253.5M | $276.6M | $295M | |
Long-Term Debt | $515.8M | $496.6M | $488M | $507.9M | $637.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1B | $1.1B | $1.1B | $1.2B | $1.4B | |
Common Stock | $286.5M | $333.9M | $336.3M | $338.9M | $342.8M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $403.3M | $465.3M | $486.4M | $510.8M | $534.1M | |
Total Liabilities and Equity | $1.5B | $1.6B | $1.6B | $1.7B | $1.9B | |
Cash and Short Terms | $6.1M | $6.5M | $6.8M | $6.3M | $10.2M | |
Total Debt | $561.6M | $568.8M | $634.9M | $682.7M | $815M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $32.2M | $36.1M | $41.4M | $45.2M | $47.1M | |
Depreciation & Amoritzation | $54.5M | $59.5M | $62.6M | $67.4M | $76.1M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$6.6M | -$17.7M | -$29.1M | $16.8M | -$11M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $75.7M | $107.8M | $97.7M | $107M | $125.9M | |
Capital Expenditures | $122.6M | $115M | $122.1M | $141M | $169.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$122.6M | -$115M | -$122.1M | -$141M | -$169.9M | |
Dividends Paid (Ex Special Dividend) | -$22.6M | -$23.6M | -$25.1M | -$26.2M | -$27.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $99.7M | $9.4M | -- | $25M | $135M | |
Long-Term Debt Repaid | -$28.8M | -$25.8M | -$10.4M | -$6.9M | -$4.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.7M | $2.3M | $9.6M | -$7.8M | -$3.7M | |
Cash From Financing | $47.7M | $7.7M | $26.9M | $31.5M | $43.8M | |
Beginning Cash (CF) | $5.2M | $6M | $6.5M | $9M | $6.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $800K | $500K | $2.5M | -$2.5M | -$200K | |
Ending Cash (CF) | $6M | $6.5M | $9M | $6.5M | $6.3M | |
Levered Free Cash Flow | -$46.9M | -$7.2M | -$24.4M | -$34M | -$44M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $18.9M | $21.5M | $24.1M | $27.2M | $27.5M | |
Depreciation & Amoritzation | $14.9M | $15.5M | $16.7M | $18M | $21.7M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $8.7M | -$3.4M | -$3.9M | -$10.5M | $11M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $47.7M | $29.1M | $15.3M | $26.6M | $52.1M | |
Capital Expenditures | $14.1M | $15.4M | $22.2M | $20.2M | $32.6M | |
Cash Acquisitions | -- | -- | -- | -- | -$71.2M | |
Cash From Investing | -$14.1M | -$15.4M | -$22.2M | -$20.2M | -$103.8M | |
Dividends Paid (Ex Special Dividend) | -$5.8M | -$6.3M | -$6.5M | -$6.8M | -$7.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $24.4M | $7.9M | $67.1M | |
Long-Term Debt Repaid | -$24.6M | -$1.3M | -$1.2M | -$1.3M | -$1.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.5M | -$6.2M | -$12.3M | -$6.7M | -$3.2M | |
Cash From Financing | -$33.5M | -$13.7M | $4.7M | -$6.6M | $55.6M | |
Beginning Cash (CF) | $6M | $6.5M | $9M | $6.5M | $6.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $100K | -- | -$2.2M | -$200K | $3.9M | |
Ending Cash (CF) | $6.1M | $6.5M | $6.8M | $6.3M | $10.2M | |
Levered Free Cash Flow | $33.6M | $13.7M | -$6.9M | $6.4M | $19.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $35.9M | $38.7M | $44M | $48.3M | $47.4M | |
Depreciation & Amoritzation | $55.9M | $60.1M | $63.8M | $68.7M | $79.8M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$5.7M | -$29.8M | -$29.6M | $10.2M | $10.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $95.5M | $89.2M | $83.9M | $118.3M | $151.4M | |
Capital Expenditures | $119.9M | $116.3M | $128.9M | $139M | $182.3M | |
Cash Acquisitions | -- | -- | -- | -- | -$71.2M | |
Cash From Investing | -$119.9M | -$116.3M | -$128.9M | -$139M | -$253.5M | |
Dividends Paid (Ex Special Dividend) | -$22.8M | -$24.1M | -$25.3M | -$26.5M | -$28M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $8.5M | $194.2M | |
Long-Term Debt Repaid | -$39M | -$2.5M | -$10.3M | -$7M | -$4.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.6M | -$400K | $3.5M | -$2.2M | -$200K | |
Cash From Financing | $24.3M | $27.5M | $45.3M | $20.2M | $106M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$100K | -- | $300K | -$500K | $3.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$24.4M | -$27.1M | -$45M | -$20.7M | -$30.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $18.9M | $21.5M | $24.1M | $27.2M | $27.5M | |
Depreciation & Amoritzation | $14.9M | $15.5M | $16.7M | $18M | $21.7M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $8.7M | -$3.4M | -$3.9M | -$10.5M | $11M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $47.7M | $29.1M | $15.3M | $26.6M | $52.1M | |
Capital Expenditures | $14.1M | $15.4M | $22.2M | $20.2M | $32.6M | |
Cash Acquisitions | -- | -- | -- | -- | -$71.2M | |
Cash From Investing | -$14.1M | -$15.4M | -$22.2M | -$20.2M | -$103.8M | |
Dividends Paid (Ex Special Dividend) | -$5.8M | -$6.3M | -$6.5M | -$6.8M | -$7.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $24.4M | $7.9M | $67.1M | |
Long-Term Debt Repaid | -$24.6M | -$1.3M | -$1.2M | -$1.3M | -$1.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.5M | -$6.2M | -$12.3M | -$6.7M | -$3.2M | |
Cash From Financing | -$33.5M | -$13.7M | $4.7M | -$6.6M | $55.6M | |
Beginning Cash (CF) | $6M | $6.5M | $9M | $6.5M | $6.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $100K | -- | -$2.2M | -$200K | $3.9M | |
Ending Cash (CF) | $6.1M | $6.5M | $6.8M | $6.3M | $10.2M | |
Levered Free Cash Flow | $33.6M | $13.7M | -$6.9M | $6.4M | $19.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.